Current Pharmaceutical Biotechnology

/Home/Lyophilization News Sources

Current Pharmaceutical Biotechnology
Aims and Scope
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in pharmaceutical biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of pharmaceutical biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Editor-in-Chief:
Alain Rolland, Vical, Inc.,San Diego, CA, USA

Associate Editors:
Paul Carter, Protein Engineering, Immunex Corp., Seattle., WA, USA
Seng H. Cheng, Gene Transfer Research, Genzyme Corporation, Framingham, MA, USA
Zeno Foldes-Papp, Clinical Immunology and Jean Dausset Lab., Graz Univ. Med. Sch. and Hospital, Graz, Austria
Seth P. Monkarsh, Department of Biopharmaceuticals, Hoffmann-La Roche Inc., Nutley, NJ, USA
Cheryl I. Murphy, Aquila Biopharmaceuticals, 175 Crossing Boulevard Suite 200, Framingham, MA, USA
Alice Riggin, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA
Johan Selmer, Novo Nordisk A/S, Novo Alle, Bagsvaerd, DENMARK
Richard I. Senderoff, Zymogenetics, Seattle, WA, USA
Steven J. Shire, Pharmaceutical R&D Dept., Genentech, Inc., South San Francisco, CA, USA
Editorial Board Members:
Dave Allen, (Lilly Research Laboratory, Indianapolis, IN, USA)
Tom Anchordoquy, (CU Health Sciences Center, Denver, CO, USA)
Esper Boel, (Novo Nordisk A/S, Bagsvaerd, DENMARK)
Jacob Bongers, (SmithKline Beecham Pharm., King of Prussia, PA, USA)
John Carpenter, (CU Health Sciences Center, Denver, CO, USA)
Steve M. Chamow, (Process Sciences., Abgenix, Inc., Fremont, CA, USA)
Byeong Chang, (Amgen Inc., Thousand Oaks, CA, USA)
Jeffrey Cleland, (Genentech, Inc., San Francisco, CA, USA)
Maureen A. Costello, (Copernicus Gene Systems, Inc., Cleveland, OH, USA)
Jan Egebjerg, (University of Aarhus, Aarhus, DENMARK)
Antonio J. Grillo-Lopez, (Idec Pharmaceuticals, San Diego, CA, USA)
David Hage, (University of Nebraska-Lincoln, Lincoln, NE, USA)
Robin E. Harkness, (Pasteur Merieux Connaught, CANADA)
Aya Jakobovits, (UroGenesys, Inc., Santa Monica, CA, USA)
Nigel Jenkins, (Lilly Research Laboratory, Indianapolis, IN, USA)
Devandra S. Kalonia, (University of Connecticut, Storrs, CT, USA)
David K. Lee, (Merck & Co., Inc., Rahway, NJ, USA)
Cheng S. Lee, (Univ. of Maryland at College Park, College Park, MD, USA)
Kam W. Leong, (Johns Hopkins University, Baltimore, MY, USA)
Ken Lewis, (ZymoGenetics, Seattle, WA, USA)
Leonard Maneri, (ICOS, Corporation, Bothel, WA, USA)
Mark C. Manning, (University of Colorado, Loveland, CO, USA)
Bruce Meiklejohn, (Lilly Research Laboratory, Indianapolis, IN, USA)
Kamlesh Patel, (SmithKline Beecham, King of Prussia, PA, USA)
Fritz Poulsen, (Novo Nordisk A/S, Bagsvaerd, DENMARK)
Steve Prestrelski, (PowderJect Technologies, Inc., Fremont, CA, USA)
Erno Pungor, (Berlex Biosciences, Richmond, CA, USA)
Gail Radcliffe, (Radcliffe Consulting Group, Worcester, MA, USA)
Theodore W. Randolph, (University of Colorado, Boulder, CO, USA)
Richard Remmele, (Immunex Corporation, Seattle, WA, USA)
Mark G.P. Saifer, (Mountain View Pharm., Inc., Menlo Park, CA, USA)
Hans T. Schambye, (MAXYGEN, H?rsholm, DENMARK)
Peter Senter, (Seattle Genetics, Inc., Bothell, WA, USA)
Alessandro Sette, (Epimmune, San Diego, CA, USA)
B. K. L Sim, (EntreMed. Inc., Rockville, MD, USA)
Cynthia L. Stevenson, (Inhale Therapeutic Systems, San Carlos, CA, USA)
Mary Stickelmeyer, (Lilly Research Laboratory, Indianapolis, IN, USA)
Stelios Tzannis, (Inhale Therapeutic Systems, San Carlos, CA, USA)
Diana L. Woehle, (Connectics Corporation, Palo Alto, CA, USA)
Janet Wolfe, (University of Tennessee, Memphis, TN, USA)
Jia-yan Wu, (Dartmouth Medical School, Hanover, NH, USA)
Gillian E. Francis, (PolyMASC Pharmaceuticals, London, U.K)
A. Filiz Oner, (Hacettepe University, Faculty of Pharmacy, Ankara, Turkey)
For general enquiries for North America only:
Bentham Science Publishers Ltd.
Mr. John F. Lehman
3 Clover Hill Circle
Ewing Township, NJ 08638-1305
USA
Tel: +1 (609) 915-4473
Fax: +1 (609) 883-7914
For subscriptions, Email: subscriptions@bentham.org
For general enquiries, Email: j.lehman@bentham.org
Bentham Science Publishers Ltd.
P.O. Box 640310
San Francisco, CA 94164-0310
USA
Fax: +1 415-775-4503